Establishment Labs Holdings Inc. Asset Impairment Charges
Establishment Labs Holdings Inc. (ESTA) reported Asset Impairment Charges of $0 for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-05-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2026-05-08
- Establishment Labs Holdings Inc. asset impairment charges for the quarter ending 2022-03-31 was $0.00.
- Establishment Labs Holdings Inc. asset impairment charges for the quarter ending 2021-06-30 was $0.00.
- Establishment Labs Holdings Inc. asset impairment charges for the quarter ending 2021-03-31 was $0.00.
- Establishment Labs Holdings Inc. asset impairment charges for the quarter ending 2020-12-31 was $0.00.
- Establishment Labs Holdings Inc. asset impairment charges for fiscal 2024 was $0.00.
- Establishment Labs Holdings Inc. asset impairment charges for fiscal 2023 was $0.00.
- Establishment Labs Holdings Inc. asset impairment charges for fiscal 2022 was $0.00.
- Establishment Labs Holdings Inc. asset impairment charges for fiscal 2021 was $0.00.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-04 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $0.00 10-Q · filed 2021-07-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $0.00 10-Q · filed 2021-07-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $0.00 10-Q · filed 2020-08-07 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |